| Application no. and date | 23152543.7 (espacenet) (Federated) (European Patent Register), 20161111 | | Patent/reg. no. and date | DK/EP 4220360, 20240626 | | Publication date | 20230802 | | Priority no. and date | EP 15194367, 20151112, EP 16189502, 20160919 | | EP pub. no. and date |
EP 4220360 20230802 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | 1717323 | | Inventor | JAGASIA, Ravi,
4070 Basel, CH,
COSTA, Veronica,
4058 Basel, CH,
HOENER, Marius,
4070 Basel, CH,
PATSCH, Christoph,
69126 Heidelberg, DE,
HEDTJÄRN, Maj, 2970 Hørsholm, DK,
JENSEN, Mads Aaboe, 2970 Hørsholm, DK,
PEDERSEN, Lykke, 2970 Hørsholm, DK,
RASMUSSEN, Søren Vestergaard, 2970 Hørsholm, DK | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C12N 15/113 (2010.01) | | Title | OLIGONUKLEOTIDER TIL INDUCERING AF PATERNEL UBE3A-EKSPRESSION | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
